Skip to main content
Log in

The prevention of antibiotic resistance during treatment

  • Published:
Infection Aims and scope Submit manuscript

Summary

Prevention of emergence of antibiotic resistance during treatment is an important goal when prescribing antimicrobials. Antibiotic resistant bacteria can emerge in three main ways—by acquisition of new genes via transposons or horizontal gene transfer, by selection of resistant variants and by selection of naturally resistant strains. In order to minimize emergence of antibiotic resistance during therapy it is important to try and avoid antibiotics which encourage the transfer of resistance genes, to avoid selection of resistant variants from susceptible pathogens and to avoid ablation of antibiotic susceptible normal flora. However, implementing these objectives is not always easy. This paper discusses possible ways of limiting the emergence of resistant bacteria during treatment. It does not consider how to prevent the spread of these strains from person to person. The prevalence of antibiotic-resistant bacteria depends, upon the selection of antibiotic-resistant strains and spread of these strains from person to person. Prevention therefore consists of two parts—the prevention of acquisition of resistance/selection of antibiotic-resistant variants and interrupting the mechanisms by which person-to-person spread can occur. This paper considers only the first of these two influences on prevalence of resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Duckworth, G. J., Williams, J. D.: Frequency of appearance of resistant variants to norfloxacin and nalidixic acid. J. Antimicrob. Chemother. 13 (Suppl. 1 B), (1984) 33–38.

    PubMed  CAS  Google Scholar 

  2. Evans, M. E., Titlow, W. B.: Levofloxacin selects fluoroquinolone-resistant methicillinStaphylococcus aureus less frequently than ciprofloxacin. J. Antimicrob. Chemother. 41 (1998) 285–288.

    Article  PubMed  CAS  Google Scholar 

  3. Riesenfeld, C., Everett, M., Piddock, L. J., Hall, B. G.: Adaptive mutations produce resistance to ciprofloxacin. Antimicrob. Agents Chemother. 41 (1997) 2059–2060.

    PubMed  CAS  Google Scholar 

  4. Sefton, A. M., Maskell, J. P., Williams, J. D.: Selection of resistant variants of respiratory pathogens by quinolones. Int. J. Antimicrob. Agents (1999) (in press).

  5. Cohen, M. A., Husband, M. D., Gage, J. W., Yoder, S. L., Roland, G. E., Gracheck, S. J.:In-vitro activity of clinafloxacin, trovafloxacin and ciprofloxacin. J. Antimicrob. Chemother. 40 (1997) 205–211.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, J.D., Sefton, A.M. The prevention of antibiotic resistance during treatment. Infection 27 (Suppl 2), S29–S31 (1999). https://doi.org/10.1007/BF02561667

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02561667

Keywords

Navigation